The frequency of RIG-I+ tumor-infiltrating CD8+ T cells was positively correlated with compromised CD8+ T cells’ survival and cytotoxicity as well as poor prognosis in CRC patients (86) (Figure 8). This evidence concerns the gene RIGI and colorectal carcinoma.